Institutional shares held 890
0 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap $41.1M
186,623,605 Shares Out.
Institutional ownership 0.0%
# of Institutions 2


Latest Institutional Activity in BIOR

Top Purchases

Q4 2024
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)
Q4 2022
Athyrium Capital Management, LP Shares Held: 42.4M ($9.32M)
Q4 2022
Armistice Capital, LLC Shares Held: 8.37M ($1.84M)
Q4 2022
Gsa Capital Partners LLP Shares Held: 2.09M ($460K)
Q4 2022
Millennium Management LLC Shares Held: 1.85M ($408K)

Top Sells

Q1 2023
State Street Corp Shares Held: 0 ($0)
Q4 2022
Susquehanna International Group, LLP Shares Held: 213K ($46.9K)
Q4 2022
Sabby Management, LLC Shares Held: 99K ($21.8K)
Q4 2022
Geode Capital Management, LLC Shares Held: 1.1M ($243K)
Q4 2022
Jane Street Group, LLC Shares Held: 10.7K ($2.36K)

About BIOR

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.


Insider Transactions at BIOR

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
50K Shares
From 4 Insiders
Grant, award, or other acquisition 50K shares
Sell / Disposition
125K Shares
From 3 Insiders
Payment of exercise price or tax liability 125K shares

Track Institutional and Insider Activities on BIOR

Follow BIORA THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIOR shares.

Notify only if
Any

Insider Trading

Get notified when an Biora Therapeutics, Inc. insider buys or sells BIOR shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to BIORA THERAPEUTICS, INC.

Track Activities on BIOR